How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/application-of-enamel-matrix-derivatives.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Application of Enamel Matrix Derivatives — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Application of Enamel Matrix Derivatives (Application of Enamel Matrix Derivatives) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Regenerative biologic / Periodontal regenerative material. Area: Dentistry / Periodontics.

marketed Regenerative biologic / Periodontal regenerative material Amelogenins and associated enamel matrix proteins Dentistry / Periodontics Biologic Live · refreshed every 30 min

Target snapshot

Application of Enamel Matrix Derivatives (Application of Enamel Matrix Derivatives) — Universidad Complutense de Madrid. Enamel matrix derivatives promote periodontal tissue regeneration by mimicking the natural proteins present during tooth development and stimulating the migration and differentiation of periodontal ligament cells.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Application of Enamel Matrix Derivatives TARGET	Application of Enamel Matrix Derivatives	Universidad Complutense de Madrid	marketed	Regenerative biologic / Periodontal regenerative material	Amelogenins and associated enamel matrix proteins
Enamel Matrix Proteins	Enamel Matrix Proteins	University of Campinas, Brazil	marketed	Regenerative biologic / Periodontal regenerative material

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Regenerative biologic / Periodontal regenerative material class)

Universidad Complutense de Madrid · 1 drug in this class
University of Campinas, Brazil · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Application of Enamel Matrix Derivatives — Competitive Intelligence Brief. https://druglandscape.com/ci/application-of-enamel-matrix-derivatives. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab